Atlas Trials

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of UB-621 in Healthy Volunteers

Clinical trial NCT02346760 · COMPLETED

Trial details

NCT number
NCT02346760
Sponsor
United BioPharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Herpes Simplex Virus Infection
Start date
2015-12-01
Primary completion
2017-01-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.